Search results
Results from the WOW.Com Content Network
The Pharmacopoeia 2018 was released by Secretary, Ministry of Health & Family Welfare, Government of India. [ 5 ] I.P. , the abbreviation of 'Indian Pharmacopoeia' is familiar to the consumers in the Indian sub-continent as a mandatory drug name suffix.
The Indian government has announced its plan to bring all medical devices, including implants and contraceptives under a review of the Central Drugs and Standard Control Organisation (CDSCO). Within the CDSCO, the Drug Controller General of India (DCGI) regulates pharmaceutical and medical devices and is positioning within the Ministry of ...
Download QR code; Print/export Download as PDF; Printable version; In other projects Wikimedia Commons; ... The International Pharmacopoeia; J. Japanese Pharmacopoeia; M.
Many developed countries set up their pharmacovigilance programs following the Thalidomide scandal in the 1960s. [2] India set up its program in the 1980s. [2] This general concept of drug safety monitoring went through different forms, but the Central Drugs Standard Control Organisation established the present Pharmacovigilance Program of India in 2010. [2]
Sir Ram Nath Chopra CIE, IMS (17 August 1882 – 13 June 1973) was an Indian Medical Service officer and a doyen of science and medicine of India. He is considered the "Father of Indian Pharmacology" for his work on pharmaceuticals and his quest for self-sufficiency of India in drugs through the experimental evaluation of indigenous and traditional drugs.
Since 1955 the Ministry regularly publishes the Indian Pharmacopoeia through the Indian Pharmacopoeia Commission (IPC), an autonomous body for setting standards for drugs, pharmaceuticals and healthcare devices and technologies in India. [4]
U.S. consumers who were “tricked” into purchases they didn't want from Fortnite maker Epic Games are now starting to receive refund checks, the Federal Trade Commission said this week. Back in ...
"Drugs and Cosmetics Rules, 1945" (PDF). Central Drugs Standard Control Organization.Archived from the original (PDF) on 31 October 2005.; A Review on the Current Classification and Regulatory Provisions for Medicines in Drug & Cosmetic Act, in the light of Present Day Context Recommendations for Drugs & Cosmetics Rules with context of Drug Schedules